CASI – casi pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CASI

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/25

09:10 am

casi

Form 6-K CASI Pharmaceuticals, For: Feb 25

High Report

Form 6-K CASI Pharmaceuticals, For: Feb 25

Report

2/20

09:00 am

casi

Form 6-K CASI Pharmaceuticals, For: Feb 20

High Report

Form 6-K CASI Pharmaceuticals, For: Feb 20

Report

2/19

09:01 am

casi

Form 6-K CASI Pharmaceuticals, For: Feb 19

Low Report

Form 6-K CASI Pharmaceuticals, For: Feb 19

Report

2/17

06:04 pm

casi

Form SCHEDULE 13G/A CASI Pharmaceuticals, Filed by: Venrock Healthcare Capital Partners III, L.P.

Medium Report

Form SCHEDULE 13G/A CASI Pharmaceuticals, Filed by: Venrock Healthcare Capital Partners III, L.P.

Report

2/13

06:04 pm

casi

Form SCHEDULE 13G/A CASI Pharmaceuticals, Filed by: Foresite Capital Fund VI LP

Low Report

Form SCHEDULE 13G/A CASI Pharmaceuticals, Filed by: Foresite Capital Fund VI LP

Report

2/10

09:00 am

casi

Form 6-K CASI Pharmaceuticals, For: Feb 10

High Report

Form 6-K CASI Pharmaceuticals, For: Feb 10

Report

2/10

06:05 am

casi

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

High Report

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

Report

1/29

07:21 pm

casi

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

Low Report

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

Report

1/28

07:17 am

casi

Form D CASI Pharmaceuticals,

Medium Report

Form D CASI Pharmaceuticals,

Report

1/28

07:13 am

casi

Form D CASI Pharmaceuticals,

Medium Report

Form D CASI Pharmaceuticals,

Report

1/22

09:00 am

casi

Form 6-K CASI Pharmaceuticals, For: Jan 22

Low Report

Form 6-K CASI Pharmaceuticals, For: Jan 22

Report

1/20

09:33 am

casi

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: Ho Chi Sing

Medium Report

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: Ho Chi Sing

Report

1/20

09:30 am

casi

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: SPARKLE BYTE LTD

Medium Report

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: SPARKLE BYTE LTD

Report

1/13

09:00 am

casi

Form 6-K CASI Pharmaceuticals, For: Jan 13

Low Report

Form 6-K CASI Pharmaceuticals, For: Jan 13

Report

1/9

06:03 am

casi

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

Low Report

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

Report

12/31

06:01 am

casi

Form 6-K CASI Pharmaceuticals, For: Dec 30

High Report

Form 6-K CASI Pharmaceuticals, For: Dec 30

Report

12/23

04:16 pm

casi

Form 6-K CASI Pharmaceuticals, For: Dec 23

Medium Report

Form 6-K CASI Pharmaceuticals, For: Dec 23

Report

12/18

06:05 am

casi

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

Low Report

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu

Report

12/17

04:15 pm

casi

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: Panacea Innovation Ltd

Low Report

Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: Panacea Innovation Ltd

Report

12/11

09:15 am

casi

Form 6-K CASI Pharmaceuticals, For: Dec 11

Medium Report

Form 6-K CASI Pharmaceuticals, For: Dec 11

Report

11/26

04:06 pm

casi

Form SCHEDULE 13G CASI Pharmaceuticals, Filed by: Chen Zhenfeng M

Low Report

Form SCHEDULE 13G CASI Pharmaceuticals, Filed by: Chen Zhenfeng M

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.